Adults, adolescents ≥ 16 years of age and elderly: Treatment of invasive candidiasis. Treatment of esophageal candidiasis in patients for whom intravenous therapy is appropriate. Prophylaxis of Candida infections in patients undergoing allogeneic hematopoietic stem cell transplantation. Children (including neonates) and adolescents < 16 years of age: Treatment of invasive candidiasis. Prophylaxis of Candida in patient undergoing hematopoietic stem cell transplantation. The decision to use Micafungin should take into account a potential risk for the development of the liver. Micafungin should therefore only be used if other antifungals are not appropriate